Immune Checkpoint Inhibitors in Cardiac Sarcoma: Reason to Take Heart? | JACC CardioOncol;6(1): 80-82, 2024 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Immune Checkpoint Inhibitors in Cardiac Sarcoma: Reason to Take Heart?

Diamond, Mark S.

Affiliation

Diamond MS; Division of Hematology Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, USA.

JACC CardioOncol ; 6(1): 80-82, 2024 Feb.

Article in En | MEDLINE | ID: mdl-38510298

Key words

cardiac tumors; immunotherapy; outcomes; sarcoma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC CardioOncol Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC CardioOncol Year: 2024 Document type: Article Affiliation country: Country of publication: